banner USF College of Arts & Sciences A-Z Index CAS USF Search OASIS myUSF

USF Home > College of Arts and Sciences > Technology & Innovation Forum: Nanotechnology

Rutledge Ellis-Behnke


Professor Rutledge Ellis-Behnke is the Director of the Nanomedicine Translational Think Tank at the Medical Faculty Mannheim of the University of Heidelberg in Germany. In addition, he is Research Affiliate in the Brain and Cognitive Sciences department at the Massachusetts Institute of Technology.

Previously he was Associate Professor in the Faculty of Medicine at the University of Hong Kong, as well as Associate Director of the Technology Transfer Office.

Ellis-Behnke is redefining tissue engineering for nanomedicine. His research in animals was the first to show the reversal of blindness; to stop bleeding in less than 15 seconds without clotting, to preserve stem cells and to immobilize prostate cancer stem cells.

He has more than 100 patent applications and his "Nano Neuro Knitting" and "Immediate Hemostasis" technologies have each been licensed to companies for translation to humans. Technology Review named his "Nanohealing" discoveries one of the "Top 10 Emerging Technologies of 2007."

Ellis-Behnke received his PhD from MIT in Neuroscience, Bachelor of Science from Rutgers University and graduated from Harvard Business School's Advanced Manager's Program (AMP).

Prior to returning to school to pursue his PhD, Ellis-Behnke held various management positions including Senior Vice President of Huntingdon, a public company for pharmaceutical testing and consulting services and co-founder/CEO in 1995 of one of the first internet companies to do online commerce. Ellis-Behnke is the Neurology Associate Editor for the journal Nanomedicine: Nanotechnology, Biology and Medicine; a Scientific Advisory Board member for the Glaucoma Foundation; an Executive Board member of the Asia Foundation for Cancer Research; and a member of the American Society of Nanomedicine, Society for Neuroscience, American Chemical Society and Sigma Xi, the scientific research society.

In addition to his work in neuroscience and nanomedicine, Ellis-Behnke introduced the TabletPC to MIT in 2001, and the University of Hong Kong in 2004, as part of the migration to the paperless classroom to deliver all course material and texts to the students digitally.


Reassembling the disassembled with the help of nanotechnology: from injured to aged

Acute and chronic central nervous system regeneration and wound stabilization therapies can (1) create an environment that will permit regeneration to allow the body to heal itself; (2) stabilize an injury site by immediate hemostasis, preserving tissue; and controlling the environment by stopping the invasion of foreign bodies, while at the same time controlling inflammation; and (3) provide an objective measure to monitor progress and status non-invasively.